173 related articles for article (PubMed ID: 33641617)
1. Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.
Zhang R; Mo WJ; Huang LS; Chen JT; Wu WZ; He WY; Feng ZB
Bioengineered; 2021 Dec; 12(1):855-874. PubMed ID: 33641617
[TBL] [Abstract][Full Text] [Related]
2. Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.
Ou Q; Ma N; Yu Z; Wang R; Hou Y; Wang Z; Chen F; Li W; Bi J; Ma J; Zhang L; Su Q; Huang X
Aging (Albany NY); 2020 Apr; 12(8):7363-7379. PubMed ID: 32341205
[TBL] [Abstract][Full Text] [Related]
3. SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer.
Hou W; Li GS; Gao L; Lu HP; Zhou HF; Kong JL; Chen G; Xia S; Wei HY
BMC Med Genomics; 2022 May; 15(1):114. PubMed ID: 35581615
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
5. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
6. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
[TBL] [Abstract][Full Text] [Related]
7. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
9. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
[TBL] [Abstract][Full Text] [Related]
10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
11. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
12. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
14. MFAP2 Promotes the Proliferation of Cancer Cells and Is Associated With a Poor Prognosis in Hepatocellular Carcinoma.
Zhu X; Cheng Y; Wu F; Sun H; Zheng W; Jiang W; Shi J; Ma S; Cao H
Technol Cancer Res Treat; 2020; 19():1533033820977524. PubMed ID: 33280519
[TBL] [Abstract][Full Text] [Related]
15. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
[TBL] [Abstract][Full Text] [Related]
16. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
17. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
[TBL] [Abstract][Full Text] [Related]
18. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
20. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
Li S; Huang J; Yang F; Zeng H; Tong Y; Li K
Sci Rep; 2021 May; 11(1):11078. PubMed ID: 34040099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
